← Open Payments lookup

JENNIFER RIVAS: Open Payments

NPI 1740676352 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,918 in 92 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $417 · 2025 $1,918

Food & beverage: $1,833Education: $85
CompanyPaymentsAmount
ABBVIE INC.22$450
Janssen Biotech, Inc.7$376
Salix Pharmaceuticals, a division of Bausch Health US, LLC22$299
Ardelyx, Inc.22$295
QOL Medical, LLC3$169
Aimmune Therapeutics, Inc.5$116
Gilead Sciences, Inc.3$72
Phathom Pharmaceuticals, Inc.4$45
GENZYME CORPORATION1$30
Regeneron Healthcare Solutions, Inc.1$26

Products named: TREMFYA, XIFAXAN, IBSRELA, Sucraid, RINVOQ, CREON, ZENPEP, MAVYRET.

Industry payments across NY — which companies pay providers there.